Top Companies and Their Offerings
| Companies | Headquarters | Outpatient & Home Infusion Services |
| Option Care Health | Bannockburn, U.S | Home Infusion Plus |
| Baxter International | Deerfield, U.S. | Infusion Therapies and Technologies |
| CVS Health | Denver, U.S. | Coram CVS Specialty Infusion Services |
| B. Braun Melsungen | Melsungen, Germany | Outpatient Services |
| UnitedHealth Group | Minnetonka, U.S. | Optum Infusion Pharmacy |
| Fresenius Kabi | Bad Homburg, Germany | Aglilia |
| Elevance Health | Plano, U.S. | Paragon Healthcare |
| KabaFusion | Cerritos, U.S. | KabaFusion |
| Cigna | Memphis, U.S | Accredo Specialty Pharmacy |
| Amedisys | Baton Rouge, U.S. | Contessa Health |
What are the Recent Developments in the Market?
- In September 2025, the launch of Advanced Infusion Care Centers (AICC) and the opening of its first location in Phoenix, AZ, were announced by Advanced Infusion Care (AIC). This launch supports the strategic commitment of the company to offer outpatient infusion therapy with enhanced patient convenience, clinical excellence, and comfort through a dedicated state-of-the-art center.
- In August 2025, Terufusion Advanced Infusion Systems was launched by Terumo India. This system integrates Smart Infusion Pump (volumetric), Pump Monitoring System software, and Smart Syringe Pump to offer precise, transparent, and efficient drug delivery along with remote monitoring, integrated drug library, and customisable dose modes.
Market Value Chain Analysis
R&D
- The R&D of the outpatient & home infusion services focuses on the development of extended stability drug formulations, AI-driven smart pumps, and remote patient monitoring platforms.
- Key players: Baxter International, Fresenius Kabi.
Clinical Trials and Regulatory Approvals
- The safety, efficacy, affordability, stability, software reliability, and user interface errors are evaluated in the clinical trials and regulatory approvals of the outpatient & home infusion services.
- Key players: Patient Support and Services
Patient Support and Services
- Comprehensive education, personalized clinical monitoring, and 24/7 nursing support are provided in the patient support and services of the outpatient & home infusion services.
- Key players: Option Care Health, Optum, CVS Health.
Market Growth
The global outpatient & home infusion services market size was estimated at USD 10.78 billion in 2025 and is predicted to increase from USD 11.78 billion in 2026 to approximately USD 26.09 billion by 2035, expanding at a CAGR of 9.24% from 2026 to 2035. The growing chronic disease burden globally is increasing the use of outpatient & home infusion services. Growing shift towards home-based care, expanding specialist therapies, technological advancements, investments, and new product launches are also enhancing the market growth.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking